Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratumoral p-toluenesulfonamide for advanced liver cancer
CTR20132279Phase 2Completed
- Sponsor
- Wu Yizhuang
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of para-toluenesulfonamide in hepatocellular carcinoma (HCC), liver cancer, sponsored by Wu Yizhuang. Started Jul 2014; status: completed.
02
Drugs
para-toluenesulfonamide
03
Conditions
hepatocellular carcinoma (HCC)liver cancer
Beyond the preview
Go deeper on CTR20132279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132279.